Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Value of BRAF Mutation in Glioblastoma.

JPMA. The Journal of the Pakistan Medical Association - 1 Jan 2024

Sohail Ayesha, Virani Qurat-Ul-Ain, Aziz Hafiza Fatima, Shamim Muhammad Shahzad

Abstract excerpt

With advances in molecular genetics, exploring targetable mutations for treating glioblastoma (GBM) patients, has become a centre of interest in modern day neuropathology. BRAF mutation has been extensively reported in several brain tumours. Recent studies report identification of BRAF mutation in GBM patients, especially isocitrate dehydrogenase wildtype glioblastomas (IDH-WT GBM), and its potential role in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioblastoma
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 38219188
DOI: 10.47391/JPMA.24-05

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Value of BRAF Mutation in Glioblastoma.PMID 38219188Read ↗

BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets.Semantic proximity Read ↗

Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis.Semantic proximity Read ↗

Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.Semantic proximity Read ↗

Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.Semantic proximity Read ↗

A practical review of prognostic correlations of molecular biomarkers in glioblastomaSemantic proximity Read ↗

BRAF mutations may identify a clinically distinct subset of glioblastoma.Semantic proximity Read ↗

BRAF-amplified glioblastoma patients have a worse prognosis than those with BRAF mutation and are associated with amplification of MET, RHEB and CUL1.Semantic proximity Read ↗

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic ImplicationsSemantic proximity Read ↗

Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.Semantic proximity Read ↗

Integrated molecular and clinical analysis of BRAF-mutant glioma in adultsSemantic proximity Read ↗

Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation.Semantic proximity Read ↗

EGFR as a clinical marker in glioblastomas and other gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.